UChicago Faculty Physician
Anand A. Patel, MD
Anand A. Patel, MD
UChicago Faculty Physician
Assistant Professor of Medicine
Medical Director, Inpatient Leukemia Service
Specialties
- Hematology and Oncology (Cancer)
Locations
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
[MUSIC PLAYING] Hi. My name is Anand Patel. I'm a hematologist, oncologist at the University of Chicago. And I focus in on taking care of patients with leukemias, myelodysplastic syndromes, and myeloproliferative diseases using a variety of treatment approaches including standard treatments and clinical-trial options. The reason I became a physician was I found it to be a perfect mix of the science that interested me while also being able to form a very direct connection with the people that I see in my day-to-day life, whether that be in the clinic, the colleagues I get to work with on the research projects that I'm excited in, and really having the direct opportunity to make an impact in the lives of the patients that we come across every day.
I was very fortunate to do my oncology training at the University of Chicago before I joined the group as a physician. And what I found in working with my cofellows, my mentors, the attending physicians is that this is an incredibly collaborative atmosphere, an incredibly collegial atmosphere, and truly a patient-first atmosphere that any of the work we do, whether it's direct clinical care or looking to advance the science of medicine through clinical research is all in the name of doing what's best for our patients.
My philosophy of care is to work very closely with my patients to find the treatment regimen or the treatment approach that's best for them. That means letting them know what I think should be recommended and then helping to bridge that with their preferences, and ultimately work together to formulate a plan that we can enact to preserve not just treatment options but also the quality of life and the preferences that are important for the patient. In my training something that I've been very fortunate to do is in addition to providing clinical care for patients, I'm an active clinical researcher and clinical investigator meaning I work very hard to try and develop and run trials that will be investigating novel therapies that can hopefully advance the standard of care for our patients while doing so in a safe way.
[MUSIC PLAYING]
I was very fortunate to do my oncology training at the University of Chicago before I joined the group as a physician. And what I found in working with my cofellows, my mentors, the attending physicians is that this is an incredibly collaborative atmosphere, an incredibly collegial atmosphere, and truly a patient-first atmosphere that any of the work we do, whether it's direct clinical care or looking to advance the science of medicine through clinical research is all in the name of doing what's best for our patients.
My philosophy of care is to work very closely with my patients to find the treatment regimen or the treatment approach that's best for them. That means letting them know what I think should be recommended and then helping to bridge that with their preferences, and ultimately work together to formulate a plan that we can enact to preserve not just treatment options but also the quality of life and the preferences that are important for the patient. In my training something that I've been very fortunate to do is in addition to providing clinical care for patients, I'm an active clinical researcher and clinical investigator meaning I work very hard to try and develop and run trials that will be investigating novel therapies that can hopefully advance the standard of care for our patients while doing so in a safe way.
[MUSIC PLAYING]
Anand Patel, MD, is board-certified hematologist-oncologist and an expert in treating myeloproliferative diseases, myelodysplastic syndromes and leukemia. In addition to providing his patients with standard treatment approaches such as chemotherapy and targeted therapies, Dr. Patel is also committed to delivering novel therapies through clinical trials that combine basic and translational research into groundbreaking advancements in medicine for better outcomes and quality of life.
Dr. Patel’s research interests are geared towards the development of clinical trials that help improve the standard of care for patients with high-risk leukemias and myeloid malignancies. His research has been published in several peer-reviewed journals, such as Blood Advances, British Journal of Haematology, Cancer, JCI Insight and Bone Marrow Transplantation. In 2024, Dr. Patel was named to the 40 Under 40 in Cancer, an award that recognizes him as one of the nation's most promising young oncology professionals and celebrates his contributions to improve the lives of those affected by cancer.
Dr. Patel’s research interests are geared towards the development of clinical trials that help improve the standard of care for patients with high-risk leukemias and myeloid malignancies. His research has been published in several peer-reviewed journals, such as Blood Advances, British Journal of Haematology, Cancer, JCI Insight and Bone Marrow Transplantation. In 2024, Dr. Patel was named to the 40 Under 40 in Cancer, an award that recognizes him as one of the nation's most promising young oncology professionals and celebrates his contributions to improve the lives of those affected by cancer.
Specialties
Areas of Expertise
- Myelodysplastic Syndromes
- Leukemia
- Acute Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- Cytopenias and other Marrow Disorders
Board Certifications
- Hematology
- Medical Oncology
- Internal Medicine
Practicing Since
- 2021
Languages Spoken
- English
Medical Education
- University of Missouri School of Medicine
Internship
- Northwestern University Feinberg School of Medicine
Residency
- Northwestern University Feinberg School of Medicine
Fellowship
- University of Chicago Medicine
Memberships & Medical Societies
- American Society of Hematology
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.